Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Cookie Johnson stood by her husband Magic's side after he was diagnosed as HIV positive, and the two have been fierce ...

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...